Amondys-45 (formerly SRP-4045) is an antisense oligonucleotide Amondys 45 [package insert]. Cambridge, MA; Sarepta Therapeutics
Viltepso [package insert]. Paramus, NJ; NS Pharma; August 2024. 4. Amondys 45 [package insert]. Cambridge, MA; Sarepta Therapeutics
Exondys 51 [package insert]. Cambridge, MA: Sarepta Therapeutics Amondys 45 [prescribing information]. Cambridge, MA: Sarepta
Viltepso [package insert]. NS Pharma, Inc. Paramus, NJ . 4. Amondys 45 Elevidys [package insert]. Sarepta Therapeutics, Inc. Cambridge MA. July
Micromedex, Clinical Pharmacology, Lexi-Drugs, national guidelines, or other peer- Amondys 45 [package insert]. Sarepta Therapeutics, Inc; Cambridge MA
Viltepso Package Insert; August 2024. 14. Sarepta Therapuetics, Inc. Amondys 45 Package Insert; Februrary 2024. 15. Study of SRP-4045 and SRP-4053 in DMD
Individual is using another exon skipping agent for DMD (including but not limited to Exondys 51, Vyondys 53); OR, Amondys 45 [package insert]
VYONDYS, VYONDYS 53, the VYONDYS 53 Logo, AMONDYS, AMONDYS 45, and the AMONDYS 45 Logo. accelerated approval status and/or FDA package insert
Amondys 45 Prescribing Information. Sarepta Therapeutics [Package Insert]. Cambridge, MA; Sarepta Therapeutics, Inc. Revised
I would like to know more about this package. ^.^